Home / Sweden / Active Biotech AB
Active Biotech AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
78 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on Active Biotech AB by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 15, 2018 | Guevoura Fund | 0.00% | |
| May 11, 2018 | Guevoura Fund | 1.13% | |
| May 10, 2018 | Guevoura Fund | 1.13% | |
| May 8, 2018 | Guevoura Fund | 0.99% | |
| May 7, 2018 | Guevoura Fund | 0.99% | |
| May 3, 2018 | Guevoura Fund | 1.46% | |
| May 2, 2018 | Guevoura Fund | 1.46% | |
| April 27, 2018 | Guevoura Fund | 1.31% | |
| April 26, 2018 | Guevoura Fund | 1.28% | |
| April 25, 2018 | Guevoura Fund | 1.28% | |
| April 19, 2018 | Guevoura Fund | 1.12% | |
| April 18, 2018 | Guevoura Fund | 1.12% | |
| April 17, 2018 | Guevoura Fund | 1.06% | |
| April 16, 2018 | Guevoura Fund | 0.94% | |
| April 15, 2018 | Guevoura Fund | 0.94% | |
| April 12, 2018 | Guevoura Fund | 0.81% | |
| April 11, 2018 | Guevoura Fund | 0.75% | |
| April 10, 2018 | Guevoura Fund | 0.75% | |
| May 28, 2015 | OrbiMed Advisors LLC | 0.52% | |
| May 27, 2015 | OrbiMed Advisors LLC | 0.52% | |
| May 26, 2015 | OrbiMed Advisors LLC | 0.65% | |
| May 25, 2015 | OrbiMed Advisors LLC | 0.65% | |
| May 19, 2015 | OrbiMed Advisors LLC | 0.78% | |
| May 18, 2015 | OrbiMed Advisors LLC | 0.84% | |
| May 17, 2015 | OrbiMed Advisors LLC | 0.84% | |
| May 11, 2015 | OrbiMed Advisors LLC | 0.95% | |
| May 10, 2015 | OrbiMed Advisors LLC | 0.95% | |
| May 7, 2015 | OrbiMed Advisors LLC | 1.05% | |
| May 6, 2015 | OrbiMed Advisors LLC | 1.05% | |
| May 5, 2015 | OrbiMed Advisors LLC | 1.11% | |
| May 4, 2015 | OrbiMed Advisors LLC | 1.11% | |
| April 29, 2015 | OrbiMed Advisors LLC | 1.22% | |
| April 28, 2015 | OrbiMed Advisors LLC | 1.22% | |
| April 16, 2015 | OrbiMed Advisors LLC | 1.46% | |
| April 15, 2015 | OrbiMed Advisors LLC | 1.46% | |
| February 27, 2015 | GSA Capital Partners LLP | 0.59% | |
| February 26, 2015 | GSA Capital Partners LLP | 0.59% | |
| January 28, 2015 | GSA Capital Partners LLP | 0.60% | |
| January 27, 2015 | GSA Capital Partners LLP | 0.60% | |
| January 19, 2015 | GSA Capital Partners LLP | 0.56% | |
| January 18, 2015 | GSA Capital Partners LLP | 0.56% | |
| December 19, 2014 | Friends Provident International Limited | 0.58% | |
| December 18, 2014 | Friends Provident International Limited | 0.58% | |
| December 3, 2014 | OrbiMed Advisors LLC | 1.44% | |
| December 2, 2014 | OrbiMed Advisors LLC | 1.44% | |
| October 17, 2014 | OrbiMed Advisors LLC | 1.73% | |
| October 16, 2014 | OrbiMed Advisors LLC | 1.73% | |
| October 14, 2014 | OrbiMed Advisors LLC | 1.62% | |
| October 13, 2014 | OrbiMed Advisors LLC | 1.62% | |
| October 6, 2014 | OrbiMed Advisors LLC | 1.40% |
Download 78 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.91% of the capital sold short
- JM AB 7.61% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.64% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.58% of the capital sold short
- RaySearch Laboratories AB (publ) 4.36% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Tobii AB 3.54% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Active Biotech AB, source Finansinspektionen, data as at May 15, 2018, https://www.quivad.com/action/active-biotech-ab